NASDAQ : NVNO

enVVeno Medical Corporation — Company profile

Healthcare · Medical Devices · United States

Last price 7.02 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.79M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company’s lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Details

NameenVVeno Medical Corporation
SectorHealthcare
IndustryMedical Devices
Employees33
Founded1987
CeoRobert Berman
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS29415J2050
Cusip29415J205
Cik0001661053
Sic3841
Stock TypeCommon Stock

Key executives

NameTitle
Robert A. BermanChief Executive Officer and Director
Jennifer Bright CPAChief Financial Officer
Dr. Hamed Alavi Ph.D.Senior Vice President and Chief Technology Officer
Dr. Marc H. Glickman M.D.Senior Vice President and Chief Medical Officer
Sandy PriettoVice President of Marketing
Avi SharmaSenior Vice President of Clinical, Regulatory and Quality

Contact

Address70 Doppler, Irvine, California 92618, United States
Phone949 261 2900
Websitehttps://www.envveno.com